How nations pursued prostate-specific antigen screening policy under restrictive guidelines: an implicit–explicit continuum

Prostate International · Published 2026-07-01 · DOI 10.1016/j.prnil.2026.07.001

Free full text

Authors (2)

Young Hwii Ko, Jae Hyun Ryu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ko, Y., Ryu, J. (2026). How nations pursued prostate-specific antigen screening policy under restrictive guidelines: an implicit–explicit continuum. Prostate International. https://doi.org/10.1016/j.prnil.2026.07.001

Related articles

• Testosterone dynamics and oncologic safety in biochemically recurrent prostate cancer: An analysis of intermittent androgen deprivation therapy schedules · Prostate International · 2026 · Same journal
• Holmium laser enucleation of the prostate versus transurethral resection of the prostate for benign prostatic hyperplasia: evidence from a Korean retrospective analysis using the Common Data Model · Prostate International · 2026 · Same journal
• Kicking the can down the road: stereotactic body radiotherapy’s role in prolonging systemic treatment efficacy in metastatic castration-resistant prostate cancer · Prostate International · 2026 · Same journal
• Clinicopathologic profile of Filipino men with low-risk prostate cancer and predictors of unfavorable pathology at radical prostatectomy · Prostate International · 2025 · Same journal
• Factors predicting the success of ejaculation preserving transurethral resection of the prostate: a prospective cohort study · Prostate International · 2026 · Same journal
• Treatment outcomes with radium-223 in patients with metastatic castration-resistant prostate cancer with bone metastasis in real-world practice: a multiinstitutional study · Prostate International · 2025 · Same journal
• Risk stratification for repeat prostate biopsy: PI-RADS 3 lesions and the differential role of PSA density · Prostate International · 2026 · Same journal
• Efficacy of tamsulosin 0.4 mg for the treatment in male with the international Prostate Symptom Score ≥ 20 compared with tamsulosin 0.2 mg · Prostate International · 2025 · Same journal
• Efficacy and safety of pentosan polysulfate therapy in patients with interstitial cystitis for relief of lower urinary tract symptoms: 15-year single center experience · Prostate International · 2025 · Same journal
• Comparative outcomes of transurethral resection of the prostate in benign prostatic hyperplasia patients with and without upper urinary tract dilatation: a propensity score matching analysis · Prostate International · 2025 · Same journal